GetTopicDetailResponse(id=fce719342b, topicName=Adalimumab, introduction=Adalimumab, content=null, image=null, comments=3, allHits=901, url=https://h5.medsci.cn/topic?id=1934, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=62362, tagList=[TagDto(tagId=62362, tagName=Adalimumab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1624314, encodeId=77a916243142d, content=<a href='/topic/show?id=fce719342b' target=_blank style='color:#2F92EE;'>#Adalimumab#</a>, objectTitle=FDA批準(zhǔn)Humira生物類似物Hulio（adalimumab-fkjp）, objectType=article, longId=197353, objectId=402219e353f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=402219e353f8, replyNumber=0, likeNumber=99, createdTime=2020-07-12, rootId=0, userName=ay2007fy, userId=eee520667499, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=402219e353f8, moduleTitle=FDA批準(zhǔn)Humira生物類似物Hulio（adalimumab-fkjp）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=402219e353f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624313, encodeId=fbe916243131c, content=<a href='/topic/show?id=fce719342b' target=_blank style='color:#2F92EE;'>#Adalimumab#</a>, objectTitle=Lancet：Secukinumab vs adalimumab用于治療銀屑病關(guān)節(jié)炎, objectType=article, longId=193804, objectId=db0219380405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db0219380405, replyNumber=0, likeNumber=74, createdTime=2020-05-10, rootId=0, userName=ay2007fy, userId=eee520667499, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db0219380405, moduleTitle=Lancet：Secukinumab vs adalimumab用于治療銀屑病關(guān)節(jié)炎, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=db0219380405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624312, encodeId=4e701624312be, content=<a href='/topic/show?id=fce719342b' target=_blank style='color:#2F92EE;'>#Adalimumab#</a>, objectTitle=Coherus宣布與AbbVie達(dá)成全球和解，確保其Adalimumab生物仿制藥CHS-1420商業(yè)化的權(quán)利, objectType=article, longId=159211, objectId=6a41159211ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a41159211ca, replyNumber=0, likeNumber=74, createdTime=2019-01-31, rootId=0, userName=ay2007fy, userId=eee520667499, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a41159211ca, moduleTitle=Coherus宣布與AbbVie達(dá)成全球和解，確保其Adalimumab生物仿制藥CHS-1420商業(yè)化的權(quán)利, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6a41159211ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
